MK0594

· Vyne Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0594, covering 2021-05-19 to 2021-05-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003) [Phase 2]